Clinical Pathways and Outcomes of Andexanet Alfa Administration for the Reversal of Critical Bleeding in Patients on Oral Direct Factor Xa Inhibitors.
Goldin M, Smith K, Koulas I, Leung T, Ravi M, Parhar S, Shah S, Floyd K, Ohanesian L, Bain R, Defonte D, Ochani K, Lin A, Patel B, Tsaftaridis N, Jnani J, Spyropoulos AC.
Goldin M, et al. Among authors: jnani j.
TH Open. 2024 May 13;8(2):e209-e215. doi: 10.1055/a-2306-0804. eCollection 2024 Apr.
TH Open. 2024.
PMID: 38741610
Free PMC article.